<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 26 Jan 2021 00:12:48 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>（2021.1.25）一致性评价名单，注射剂扎堆过评</title><link>https://mp.weixin.qq.com/s/rJMOUen8-CGIx4xCjFa08Q</link><description></description><content:encoded><![CDATA[（2021.1.25）一致性评价名单，注射剂扎堆过评]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>这些临床大品种，带量采购后平均降价67.3%！</title><link>https://mp.weixin.qq.com/s/15Rio1VimrgcWk-4oc4nUg</link><description></description><content:encoded><![CDATA[这些临床大品种，带量采购后平均降价67.3%！]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>第三十六批参比目录发布，59个新增，6个持证增加...</title><link>https://mp.weixin.qq.com/s/SmqRoTRr5zdCQCWfaLdiYQ</link><description></description><content:encoded><![CDATA[第三十六批参比目录发布，59个新增，6个持证增加...]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>第四批国采，官方细则解读来了</title><link>https://mp.weixin.qq.com/s/Y479vkvpADGLO2jSbTnO0Q</link><description></description><content:encoded><![CDATA[第四批国采，官方细则解读来了]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>未过评药品，“大限”已到！</title><link>https://mp.weixin.qq.com/s/oXQow_tsA0MQ32b-7Hz17g</link><description></description><content:encoded><![CDATA[未过评药品，“大限”已到！]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>医保局似曾相识的“招数”，第四批集采得注意了！</title><link>https://mp.weixin.qq.com/s/whWiAtFS6zDS6lLEST_2nw</link><description></description><content:encoded><![CDATA[医保局似曾相识的“招数”，第四批集采得注意了！]]></content:encoded><pubDate>Sat, 23 Jan 2021 21:41:13 +0800</pubDate></item><item><title>百亿BTK抑制剂市场，多少品种在伺机待发？</title><link>https://mp.weixin.qq.com/s/0l9aBe65PFZwLe-zxna-Hw</link><description></description><content:encoded><![CDATA[百亿BTK抑制剂市场，多少品种在伺机待发？]]></content:encoded><pubDate>Fri, 22 Jan 2021 21:50:28 +0800</pubDate></item><item><title>最新第四批国采竞争格局，3品种超13家企业同台角逐！</title><link>https://mp.weixin.qq.com/s/hLdOajupSVGTR4MYtfc1nQ</link><description></description><content:encoded><![CDATA[最新第四批国采竞争格局，3品种超13家企业同台角逐！]]></content:encoded><pubDate>Fri, 22 Jan 2021 21:50:28 +0800</pubDate></item><item><title>42个自费药议价挂网</title><link>https://mp.weixin.qq.com/s/RCWxbn_BcXQH8RTId_MZeg</link><description></description><content:encoded><![CDATA[42个自费药议价挂网]]></content:encoded><pubDate>Fri, 22 Jan 2021 21:50:28 +0800</pubDate></item><item><title>注意！这些药品不许卖了</title><link>https://mp.weixin.qq.com/s/SxjEuD1OrGvJAeGyOXr-Kg</link><description></description><content:encoded><![CDATA[注意！这些药品不许卖了]]></content:encoded><pubDate>Fri, 22 Jan 2021 21:50:28 +0800</pubDate></item><item><title>（2021.1.21）一致性评价最新名单来了！</title><link>https://mp.weixin.qq.com/s/vjMnaZUuXX5sPSlQg3woWg</link><description></description><content:encoded><![CDATA[（2021.1.21）一致性评价最新名单来了！]]></content:encoded><pubDate>Thu, 21 Jan 2021 21:43:22 +0800</pubDate></item><item><title>31个过评大品种，全国最低价出售</title><link>https://mp.weixin.qq.com/s/anYxoRr1ssOW2OssdElTWQ</link><description></description><content:encoded><![CDATA[31个过评大品种，全国最低价出售]]></content:encoded><pubDate>Thu, 21 Jan 2021 21:43:22 +0800</pubDate></item><item><title>这个药，恢复供应了！</title><link>https://mp.weixin.qq.com/s/0OOqWzsxYnFA36hG96ro-g</link><description></description><content:encoded><![CDATA[这个药，恢复供应了！]]></content:encoded><pubDate>Thu, 21 Jan 2021 21:43:22 +0800</pubDate></item><item><title>第四批国采，最新官方消息流出...</title><link>https://mp.weixin.qq.com/s/LmO4CKlwFxznR8_8s2EyCQ</link><description></description><content:encoded><![CDATA[第四批国采，最新官方消息流出...]]></content:encoded><pubDate>Thu, 21 Jan 2021 21:43:22 +0800</pubDate></item><item><title>一致性评价排行榜：中国生物制药拔得头筹！</title><link>https://mp.weixin.qq.com/s/LN_KobKioieSI0jULF6Zag</link><description></description><content:encoded><![CDATA[一致性评价排行榜：中国生物制药拔得头筹！]]></content:encoded><pubDate>Wed, 20 Jan 2021 21:35:18 +0800</pubDate></item><item><title>一批药品下调价格，降幅高达72%！</title><link>https://mp.weixin.qq.com/s/1wkaqC2RwNfIpOGxQI87tw</link><description></description><content:encoded><![CDATA[一批药品下调价格，降幅高达72%！]]></content:encoded><pubDate>Wed, 20 Jan 2021 21:35:18 +0800</pubDate></item><item><title>鲁南制药：一款抗炎镇痛药首家过评</title><link>https://mp.weixin.qq.com/s/QraflkaqQ2fBxMK79U2WEg</link><description></description><content:encoded><![CDATA[鲁南制药：一款抗炎镇痛药首家过评]]></content:encoded><pubDate>Wed, 20 Jan 2021 21:35:18 +0800</pubDate></item><item><title>新增165个药品挂网，涉及阿卡波糖、利伐沙班、阿法替尼...</title><link>https://mp.weixin.qq.com/s/Ztd-mo5HVBM20TrgzMwXTg</link><description></description><content:encoded><![CDATA[新增165个药品挂网，涉及阿卡波糖、利伐沙班、阿法替尼...]]></content:encoded><pubDate>Wed, 20 Jan 2021 21:35:18 +0800</pubDate></item><item><title>剂型多变，「布洛芬」玩转300亿抗炎抗风湿药市场</title><link>https://mp.weixin.qq.com/s/rT_v9EmoK8lPKofb_RL4Jg</link><description></description><content:encoded><![CDATA[剂型多变，「布洛芬」玩转300亿抗炎抗风湿药市场]]></content:encoded><pubDate>Tue, 19 Jan 2021 21:37:07 +0800</pubDate></item><item><title>药价联动调整，注射剂最高降价64.5%！</title><link>https://mp.weixin.qq.com/s/ezUNAjfWTButmd8pQyEJvw</link><description></description><content:encoded><![CDATA[药价联动调整，注射剂最高降价64.5%！]]></content:encoded><pubDate>Tue, 19 Jan 2021 21:37:07 +0800</pubDate></item></channel></rss>